when does retatrutide come out UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide Commercial Availability Timeline: Key
Description
If you accidentally take too much : GLP-1 receptor agonist overdose can cause severe nausea, vomiting, and potentially hypoglycemia, particularly in patients taking concurrent insulin or sulfonylureas (GLP-1 medications alone rarely cause hypoglycemia)
NICE recommends GLP-1 receptor agonists for type 2 diabetes when metformin and other oral medications fail to achieve adequate glycaemic control, particularly with BMI 35 kg/m or weight-related comorbidities
That's a win for patients
Maintenance dosing considerations Not everyone needs or tolerates the 12mg maximum dose
[PubMed Central ID: PMC2597770]
